凝介导的瘤T细胞透和免疫逃避,以加强癌症免疫疗法
Guixiang Xu1, Kai Liu2, Xiangwu Chen1
1Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China. hewenxiu@sdu.edu.cn.
Nanoscale horizons
|December 12, 2023
概括
这项研究引入了一种可注射的水凝,通过改善T细胞透和阻止PD-L1免疫逃避来增强癌症免疫疗法. 这种新的方法提供了一种有效的策略来对抗瘤和转移.
科学领域:
- 生物医学工程 生物医学工程
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 癌症免疫疗法面临的挑战是有限的T细胞透和PD-L1介导的免疫逃避.
- 需要有效的策略来克服这些障碍,以改善治疗结果.
研究的目的:
- 开发一种可注射的水凝系统,用于增强癌症免疫治疗.
- 为了加强T细胞的透,并使PD-L1免疫检查点失活.
主要方法:
- 使用含有林格利和BMS-202颗粒的藻酸盐 (SA) 制备了一种可注射的水凝.
- 林格利普丁稳定了CXCL10的持续T细胞化学反应,而BMS-202则在瘤细胞上禁用了PD-L1.
主要成果:
- 水凝促进了T细胞大量透到瘤中.
- 结合治疗通过克服PD-L1免疫逃避,有效地抑制了初级瘤,远程瘤和肺转移.
结论:
- 开发的水凝平台为癌症免疫治疗提供了强大的方法.
- 这项研究提出了一种新的策略,用于增强T细胞功能,克服瘤中的免疫抑制.
相关概念视频
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


